comparemela.com
Home
Live Updates
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC : comparemela.com
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
TOKYO and XIAMEN, China, March 27, 2023 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour... | March 27, 2023
Related Keywords
Malaysia
,
Pan Lung
,
Sichuan
,
China
,
Amoy
,
Fujian
,
Japan
,
Taiwan
,
South Korea
,
Xiamen
,
Tokyo
,
Thailand
,
Japanese
,
Paul Huang
,
Kenji Iwakabe
,
Vivian Liu
,
Wenn Sun
,
Panel The Amoydx
,
Precision Medicine Asia Co Ltd
,
Amoy Diagnostics Co Ltd Amoydx
,
Japanese Ministry Of Health
,
Riken Genesis Co Ltd
,
Amoy Diagnostics Co Ltd
,
Marketing Department
,
Holdings Hk Ltd
,
Globenewswire Inc
,
Chief Executive Officer
,
Riken Genesis
,
Mou Zheng
,
Marketing Authorization
,
Precision Medicine Asia
,
Amoy Diagnostics Co
,
Td Stock Exchange
,
News
,
Information
,
Press Release
,
End
,
Arch
,
023
,
Aiken
,
Genesis
,
Iagnostics
,
Precision
,
Medicine
,
Sia
,
Oday
,
Nnounced
,
Hat
,
The
,
Ministry
,
F 300685 Cne1000034d3
,
comparemela.com © 2020. All Rights Reserved.